CUL2 and hepatocellular carcinoma: Twist, a vital EMT-TF, combines with the promoter of Cul2 to increase the expression of circCul2 (hsa_circ_10720), which binds to a set of miRNAs to increase vimentin expression in hepatocellular carcinoma (HCC)31 (Figure 2A).